Gyros Protein Technologies
  • IMMUNOASSAY SOLUTIONS
  • PEPTIDE SYNTHESIZERS
  • CORPORATE
  • Interests
    • COVID-19
    • Immunoassays
    • Cell & Gene Therapy
    • Vaccines
  • Products
    • Gyrolab Systems
      • Gyrolab xPlore
      • Gyrolab xPand
    • Consumables
      • Gyrolab CDs
      • Gyrolab Kits and Solutions
      • Buffers and Accessories
    • Gyrolab Assay Protocols
    • Gyrolab Software
    • Gyrolab Custom Assay Services
      • Biomolecule Labeling 
      • Custom Assay Development 
      • Custom Kit Development 
    • Service and Support
  • Applications
    • Pre-clinical
      • Pharmacokinetics (PK)/Toxicokinetics (TK)
      • Biomarker Monitoring & Pharmacodynamics (PD)
      • Affinity
      • Immunogenicity
    • Clinical
      • Pharmacokinetics (PK)/Toxicokinetics (TK)
      • Biomarker Monitoring & Pharmacodynamics (PD)
      • Affinity
      • Immunogenicity
    • Bioprocess
      • Impurity Testing
      • Product Titer Quantification
      • Affinity
  • Resources
    • Gyrolab User Zone
    • SpinBlog
    • Gyrolab Assay Protocols
    • References
    • Brochures
    • Product Information Sheets
    • Application Notes
    • Application Reports
    • Technical Notes
    • Case Studies
    • Posters
    • Seminars
    • Webinars
    • White Papers
    • Certificate of Analysis
    • Instructions for Use
    • MSDS
  • About Us
    • Why Gyrolab
    • Technology
    • Installations Worldwide
    • CRO Partners
    • History
    • News
  • Contact
    • Sales and Support by Region
    • Ordering Information
    • Order Placement
    • Terms & Conditions
Share
  • Share on Facebook
  • Tweet
  • Share on Google+
  • Share on LinkedIn
  • Send email
Subscribe

Gyrolab Spin Blog: gyrolab-xpand

Mar 19, 2018 3:30:00 PM

Latest news from BPI West: Gyrolab xPand speeds up the implementation of QbD

  • Tweet

 

Gyrolab_xPand_blog.pngThis year, Bioprocess International West brings together attendees from different departments to share challenges and discuss the “solutions needed to improve the speed, lower the cost and increase the quality of biologics development”. We are proud to announce a new system that is aimed at doing exactly that: Gyrolab® xPand.

Read More
0 Comments Click here to read/write comments

Topics: Gyrolab xPand


All posts

Recent Posts

Related Topic

  • Pharmacokinetics (10)
  • Assay Development (8)
  • Immunoassay (8)
  • Gyrolab system (5)
  • Vaccine (5)
  • Matrix (4)
  • Regulated bioanalysis (4)
  • ADA (3)
  • Affinity (3)
  • Gene therapy (3)
  • HCP (3)
  • Toxicokinetics (3)
  • Affinity determination (2)
  • Bioprocess (2)
  • Clinical trial (2)
  • Immunogenicity (2)
  • Impurity testing (2)
  • Microsampling (2)
  • ADME (1)
  • Affinity in solution (1)
  • Antibody-Drug Conjugate (1)
  • Assay Automation (1)
  • Autoantibodies (1)
  • COVID-19 (1)
  • CRO transfer (1)
  • Clinical samples (1)
  • Crohn's disease (1)
  • Diabetes (1)
  • GLP-1 (1)
  • Gyrolab xPand (1)
  • Gyros (1)
  • Host Cell Proteins (1)
  • Immunoassay platform (1)
  • Infectious Diseases (1)
  • Multiplexing (1)
  • Obesity (1)
  • Phase III studies (1)
  • Preclinical studies (1)
  • Publications (1)
  • Symphony peptide synthesizer (1)
  • Ulcerative colitis (1)
  • solid-phase peptide synthesis (1)
see all
Peptide-synthesizers.png

Get in touch

+46 18 566 300

 

Newsletter sign up!

FacebookLinkedin
  • gyrosproteintechnologies.com
  • Site Use Terms
  • Privacy Policy
  • Legal Notice
Copyright © 2021 Gyros Protein Technologies AB All Rights Reserved.